Effect of renin-angiotensin system on senescence

Masaki Mogi1

  • 1Department of Pharmacology, Ehime University Graduate School of Medicine, Ehime, Japan.

Insights

The renin-angiotensin system (RAS) impacts aging and organ function. Inhibiting the Ang II type 1 receptor may extend lifespan, while the ACE2/Ang (1-7)/Mas axis offers protective benefits.

Area of Science:

  • Physiology
  • Gerontology
  • Cardiovascular Research

Background:

  • The renin-angiotensin system (RAS) regulates blood pressure and sodium balance.
  • RAS activation, particularly the ACE/Ang II/AT1R axis, contributes to cellular senescence and organ dysfunction via reactive oxygen species.
  • Dysfunction in vasculature, brain, kidney, and skeletal muscle is linked to RAS overactivation, causing diseases like atherosclerosis, stroke, CKD, and sarcopenia.

Purpose of the Study:

  • To review the impact of RAS on age-related tissue dysfunction.
  • To explore both the detrimental effects of the classical RAS axis and the protective roles of the ACE2/Ang (1-7)/Mas axis.
  • To examine RAS's influence on lifespan, referencing gene-modification models.

Main Methods:

  • Literature review of studies on RAS and aging.
  • Analysis of gene-modification models, including mice lacking the Ang II type 1 receptor.
  • Examination of organ-specific effects of RAS activation and inhibition.

Main Results:

  • Overactivation of the ACE/Ang II/AT1R axis promotes senescence and organ damage.
  • Mice lacking the Ang II type 1 receptor demonstrated increased lifespan compared to controls.
  • The ACE2/Ang (1-7)/Mas axis exhibits protective functions against age-related dysfunction.

Conclusions:

  • RAS significantly influences age-related tissue dysfunction and lifespan.
  • Targeting the classical RAS axis may mitigate age-related diseases.
  • The ACE2/Ang (1-7)/Mas axis represents a potential therapeutic target for promoting healthy aging.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.4K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
810
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
618
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K